Latest Period
Q2 2026
Security Snapshot
Gabelli Healthcare & WellnessRx Trust - Common Shares, $0.001 par value (GRX) Institutional Ownership
CUSIP: 36246K103
13F Institutional Holders and Ownership History from Q1 2014 to Q2 2026
Institutions Reporting
51
Shares (Excl. Options)
5,882,526
Price
$9.45
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Shares, $0.001 par value
- Symbol
- GRX on NYSE
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 5,882,526
- Total 13F value
- $55,591,005
- Portfolio coverage rank
- 0%
- Share change
- -61,766
- Value change
- -$556,551
- Number of holders
- 51
- Shares outstanding
- 15,447,782
- SEC-reported price per share
- $9.47
- Insider filing price
- $9.47
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- GRX - Gabelli Healthcare & WellnessRx Trust - Common Shares, $0.001 par value is tracked under CUSIP 36246K103.
- 51 institutions reported positions in Q2 2026.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 51 to 51 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $53,805,869 to $55,591,005.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 51 institutions filings for Q2 2026.
Security key
36246K103
Latest holder period
Q2 2026
13F holders
51
13D/G owners
2
CIK / CUSIP context first
Open Q2 2026 holders
GRX full holder history
Gabelli Healthcare & WellnessRx Trust SEC filings
Gabelli Healthcare & WellnessRx Trust insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 36246K103:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
GRX
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Saba Capital Management, L.P. | 13% | +7.9% | $18,634,814 | +$1,167,200 | 2,054,555 | +6.7% | Saba Capital Management, L.P. | 16 Oct 2025 |
| SIT INVESTMENT ASSOCIATES INC | 5.4% | $7,912,344 | 833,756 | Sit Investment Associates, Inc. | 30 Sep 2025 |
As of 30 Jun 2026, 51 institutional investors reported holding 5,882,526 shares of Gabelli Healthcare & WellnessRx Trust - Common Shares, $0.001 par value (GRX). This represents 38% of the company’s total 15,447,782 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
38%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Saba Capital Management, L.P. | 14% | 2,118,201 | 0% | 0.61% | $20,016,999 |
| SIT INVESTMENT ASSOCIATES INC | 7.8% | 1,198,562 | 0% | 0.21% | $11,326,000 |
| GAMCO INVESTORS, INC. ET AL | 2.2% | 346,026 | 0% | 0.03% | $3,269,944 |
| BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC | 2.1% | 327,658 | +6.1% | 0.39% | $3,096,363 |
| LPL Financial LLC | 1.7% | 259,281 | -6.8% | 0% | $2,450,209 |
| WELLS FARGO & COMPANY/MN | 1.6% | 253,218 | -2.1% | 0% | $2,392,912 |
| MORGAN STANLEY | 1.5% | 228,713 | +8.5% | 0% | $2,161,341 |
| EVOLVE PRIVATE WEALTH, LLC | 1.1% | 176,625 | -1.1% | 0.1% | $1,669,106 |
| Aviance Capital Partners, LLC | 1.1% | 171,442 | +0.07% | 0.17% | $1,620,130 |
| STEPHENS INC /AR/ | 0.77% | 118,349 | -1.9% | 0.01% | $1,118,398 |
| CAPSTONE INVESTMENT ADVISORS, LLC | 0.64% | 99,441 | 0% | 0.01% | $939,717 |
| &PARTNERS | 0.61% | 93,507 | -11% | 0% | $881,871 |
| UHLMANN PRICE SECURITIES, LLC | 0.5% | 77,700 | +26% | 0.03% | $734,314 |
| NewEdge Advisors, LLC | 0.43% | 66,589 | -1.1% | 0% | $629,268 |
| Atlas Wealth LLC | 0.4% | 61,294 | 0.08% | $579,228 | |
| Creative Planning | 0.17% | 27,005 | -0.52% | 0% | $255,195 |
| Janney Montgomery Scott LLC | 0.17% | 26,872 | -6% | 0% | $254,000 |
| Beacon Pointe Advisors, LLC | 0.16% | 24,055 | -26% | 0% | $227,320 |
| Alessandra Capital Management, LLC | 0.15% | 23,087 | -22% | 0.15% | $218,172 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 0.14% | 22,186 | -2.2% | 0% | $212,987 |
| Waverly Advisors, LLC | 0.13% | 20,290 | -27% | 0% | $191,739 |
| UBS Group AG | 0.12% | 19,116 | -67% | 0% | $180,646 |
| COMMONWEALTH EQUITY SERVICES, LLC | 0.09% | 14,563 | +0.01% | 0% | $137,620 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.09% | 13,947 | -25% | 0% | $131,799 |
| CITADEL ADVISORS LLC | 0.09% | 13,897 | 0% | $131,327 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
50
Latest
Q2 2026
Rows shown
1-25 of 50
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 5,882,526 | $55,591,005 | -$556,551 | $9.45 | 51 |
| 2026 Q1 | 5,945,142 | $53,805,869 | +$93,528 | $9.05 | 51 |
| 2025 Q4 | 5,930,184 | $57,107,661 | +$937,653 | $9.63 | 53 |
| 2025 Q3 | 5,647,549 | $51,236,923 | +$1,958,322 | $9.07 | 54 |
| 2025 Q2 | 5,429,514 | $51,318,980 | +$1,090,583 | $9.45 | 58 |
| 2025 Q1 | 5,185,556 | $52,270,856 | +$718,989 | $10.08 | 61 |
| 2024 Q4 | 5,270,301 | $50,912,869 | +$3,900,325 | $9.64 | 67 |
| 2024 Q3 | 4,857,274 | $53,072,330 | +$3,192,330 | $10.95 | 66 |
| 2024 Q2 | 4,590,471 | $43,930,948 | +$790,501 | $9.58 | 67 |
| 2024 Q1 | 4,363,392 | $44,668,783 | +$1,228,402 | $10.24 | 68 |
| 2023 Q4 | 4,287,218 | $39,995,577 | +$1,936,192 | $9.33 | 71 |
| 2023 Q3 | 4,092,087 | $35,099,311 | +$881,876 | $8.58 | 71 |
| 2023 Q2 | 3,989,120 | $39,717,899 | -$844,353 | $9.96 | 71 |
| 2023 Q1 | 4,070,996 | $41,067,738 | +$665,564 | $10.09 | 69 |
| 2022 Q4 | 4,166,306 | $42,829,596 | +$1,398,554 | $10.28 | 67 |
| 2022 Q3 | 3,953,651 | $37,573,339 | -$1,545,108 | $9.50 | 55 |
| 2022 Q2 | 4,110,603 | $44,065,987 | +$1,682,020 | $10.72 | 58 |
| 2022 Q1 | 3,952,914 | $50,670,179 | -$3,968,218 | $12.82 | 53 |
| 2021 Q4 | 4,132,189 | $56,069,916 | -$5,307,668 | $13.57 | 53 |
| 2021 Q3 | 4,560,120 | $60,237,215 | -$4,106,549 | $13.21 | 50 |
| 2021 Q2 | 4,917,592 | $66,379,242 | -$3,990,032 | $13.50 | 57 |
| 2021 Q1 | 5,215,180 | $64,977,146 | -$866,262 | $12.46 | 59 |
| 2020 Q4 | 5,288,796 | $63,192,100 | +$852,113 | $11.95 | 58 |
| 2020 Q3 | 5,197,261 | $53,601,949 | -$1,789,951 | $10.32 | 57 |
| 2020 Q2 | 6,530,982 | $65,579,924 | -$19,032 | $10.04 | 56 |